Nielsen H E, Saksø P, Skorgaard Poulsen H, Gadeberg C C
Acta Radiol Oncol. 1985 May-Jun;24(3):247-51. doi: 10.3109/02841868509134395.
The investigation was carried out to elucidate a possible relationship between the amount of estrogen receptors and bone mineral content in patients with breast tumors. Bone mineral content (BMC) was measured by photon absorptiometry in the distal forearm of 54 women with untreated breast carcinoma and 19 with benign breast tumor. The concentration of unoccupied high affinity estrogen receptors was measured in breast tumor biopsy specimens. Higher values of BMC were found in the total group of estrogen receptor-positive patients with breast carcinoma compared with estrogen receptor-negative patients, but not after dividing the patients into smaller groups according to age. No significant correlation could be seen between the amount of estrogen receptors and bone mineral content. In conclusion the present study could not support a relationship between the amount of estrogen receptors in breast cancer tissue and the amount of bone mineral and bone mass in women with breast tumors.
开展这项调查是为了阐明乳腺肿瘤患者雌激素受体数量与骨矿物质含量之间可能存在的关系。采用光子吸收法测量了54例未经治疗的乳腺癌女性患者和19例乳腺良性肿瘤女性患者前臂远端的骨矿物质含量(BMC)。在乳腺肿瘤活检标本中测量了未占据的高亲和力雌激素受体的浓度。与雌激素受体阴性的乳腺癌患者相比,雌激素受体阳性的乳腺癌患者总体组的BMC值更高,但根据年龄将患者分为较小的组后则未发现这种差异。雌激素受体数量与骨矿物质含量之间未见显著相关性。总之,本研究不支持乳腺癌组织中雌激素受体数量与乳腺肿瘤女性患者的骨矿物质含量及骨量之间存在关联。